Section 68
Chapter 67,147

138Pd_Pr Patient-reported outcomes (Pros) in Alex: A phase Iii study of alectinib (Alec) vs crizotinib (Criz) in non-small-cell lung cancer (Nsclc)

Perol, M.; Peters, S.; Pavlakis, N.; Levchenko, E.; Platania, M.; Oliveira, J.; Novello, S.; Karagiannis, T.; Zeaiter, A.; Dziadziuszko, R.

Journal of Thoracic Oncology 13(4): S80-S81


ISSN/ISBN: 1556-0864
DOI: 10.1016/s1556-0864(18)30412-x
Accession: 067146898

PDF emailed within 0-6 h: $19.90